98-3900. Certain Other Dosage Form New Animal Drugs; Tricaine Methanesulfonate  

  • [Federal Register Volume 63, Number 31 (Tuesday, February 17, 1998)]
    [Rules and Regulations]
    [Pages 7702-7703]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-3900]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 529
    
    
    Certain Other Dosage Form New Animal Drugs; Tricaine 
    Methanesulfonate
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulations to reflect approval of an abbreviated new animal drug 
    application (ANADA) filed by Western Chemical, Inc. The ANADA provides 
    for the use of tricaine methanesulfonate in the water of fish and other 
    cold-blooded aquatic animals for temporary immobilization.
    
    EFFECTIVE DATE: February 17, 1998
    
    FOR FURTHER INFORMATION CONTACT: Lonnie W. Luther, Center for 
    Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-827-0209.
    
    SUPPLEMENTARY INFORMATION: Western Chemical, Inc., 1269 Lattimore Rd., 
    Ferndale, WA 98248, is the sponsor of ANADA 200-226, which provides for 
    the use of tricaine methanesulfonate powder to be mixed in the water of 
    fish and other cold-blooded animals to be used for anesthesia and 
    tranquilization. Western Chemical's ANADA 200-226 is approved as a 
    generic copy of Argent Chemical Laboratories' NADA 42-427 
    Finquel. The ANADA is approved as of November 21, 1997, and 
    the regulations are amended in 21 CFR 529.2503(b) to reflect the 
    approval. The basis of approval is discussed in the freedom of 
    information summary.
        In accordance with the freedom of information provisions of 21 CFR 
    part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness 
    data and information submitted to support approval of this application 
    may be seen in the Dockets Management Branch (HFA-305), Food and Drug 
    Administration, 12420 Parklawn Dr., rm. 1-23, Rockville, MD 20857, 
    between 9 a.m. to 4 p.m., Monday through Friday.
        The agency has determined under 21 CFR 25.33(a)(1) that this action 
    is of a type that does not individually or cumulatively have a 
    significant effect on the human environment. Therefore, neither an 
    environmental assessment nor an environmental impact statement is 
    required.
    
    List of Subjects in 21 CFR Part 529
    
        Animal drugs.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs and 
    redelegated to the Center for Veterinary Medicine, 21 CFR part 529 is 
    amended as follows:
    
    PART 529--CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS
    
        1. The authority citation for 21 CFR part 529 continues to read as 
    follows:
    
        Authority: 21 U.S.C. 360b.
    
    
    Sec. 529.2503  [Amended]
    
        2. Section 529.2503 Tricaine methanesulfonate is amended in 
    paragraph (b) by removing ``No.
    
    [[Page 7703]]
    
    051212'' and adding in its place ``Nos. 050378 and 051212''.
    
        Dated: January 21, 1998.
     Stephen F. Sundlof,
     Director, Center for Veterinary Medicine.
    [FR Doc. 98-3900 Filed 2-13-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
2/17/1998
Published:
02/17/1998
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
98-3900
Dates:
February 17, 1998
Pages:
7702-7703 (2 pages)
PDF File:
98-3900.pdf
CFR: (1)
21 CFR 529.2503